FENO, Extended NO Analysis and NO/CO Diffusing Capacity in Thoracic Radiation Therapy
- Conditions
- Radiotherapy
- Registration Number
- NCT03431740
- Lead Sponsor
- University of Zurich
- Brief Summary
The investigators aim to investigate the impact of thoracic radiation therapy on diffusion capacity of the lung (primary endpoint: diffusion capacity for nitric oxide, DLNO) and on exhaled nitric oxide.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 3
- planned but not already commenced radiation therapy (RT) of the chest, with or without pre-RT surgery.
- signed informed consent of the participant
- thoracic RT in the past
- treatment with immune checkpoint inhibitors
- unstable condition affecting participation in the measurements
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in diffusing capacity for nitric oxide (DLNO) Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT
- Secondary Outcome Measures
Name Time Method Pulmonary capillary blood volume (Vc) Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT This variable is a calculated variable. The course over time will be described.
Transfer Coefficient for nitric oxide (DLNO/VA) Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT The course over time will be described.
Alveolar Volume (VA) Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT This variable is a calculated variable. The course over time will be described.
Forced expiratory flow between 25% and 75% of forced vital capacity Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT The course over time will be described.
Transfer Coefficient for carbon monoxide (DLCO/VA) Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT The course over time will be described.
Ratio of DLNO and DLCO Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT The course over time will be described.
Alveolar-capillary membrane-diffusing capacity for carbon monoxide (DMCO) Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT The course over time will be described.
Concentration of nitric oxide in the gas phase of the alveolar or acinar region (CANO) Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT The course over time will be described.
Tissue concentration of nitric oxide of the airway wall (CawNO) Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT The course over time will be described.
Forced expiratory volume in 1 second Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT The course over time will be described.
Diffusing capacity for carbon monoxide (DLCO) Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT The course over time will be described.
Airway compartment diffusing capacity of nitric oxide from the of of the airway wall to the gas stream (DawNO) Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT The course over time will be described.
Total flux of nitric oxide in the conducting airway compartment (JawNO) Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT The course over time will be described.
Fractional concentration of exhaled nitric oxide at a flow rate of 50mL/s (FENO50) Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT The course over time will be described.
Forced vital capacity Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT The course over time will be described.
Trial Locations
- Locations (1)
University Hospital of Zurich
🇨ðŸ‡Zürich, Switzerland